
Nicotinamide Adenosine Dinucleotide (NAD+) has received a lot of attention in the longevity world in recent years. There has been a surge of interest, both scientific and commercial, and many of the well-known thought leaders in the field have devoted significant attention to the subject in the form of research, podcasts, supplements, blogs, etc. It is a topic that I get asked about all the time by patients, many of whom already have some experience receiving NAD+ in the form of IV Infusions or taking supplements containing oral NAD+ precursors.
The Science Behind NAD+
What is NAD+? NAD+ is a molecule that is found in every cell and acts as an enzyme cofactor in hundreds of metabolic reactions, including the foundational chemical reactions that produce energy. A good understanding of NAD+ requires a knowledge of biochemistry that would challenge even the brainiest of medical students, and I will not attempt to describe NAD+ on that level in this article (there are plenty of good reviews out there if you are interested to read more, some of which I have listed in the Reference section below).
On a high level, however, NAD+ plays a central role in many key cellular functions, including metabolic pathways, DNA repair, cellular senescence and immune cell function. Aging is accompanied by a gradual decline in cellular NAD+ levels in humans as well as multiple animal models. This decline in NAD+ is linked to the development and progression of numerous aging-related diseases, including cognitive decline, cancer, metabolic disease, arthritis, and sarcopenia.
Numerous NAD+ IV infusion protocols have been developed with the goal of preventing age related disease and providing a wide variety of benefits including increasing energy, improving sleep patterns, improving mood, promoting neuroplasticity and brain repair, enhancing mental clarity and focus, boosting the immune system, decreasing inflammation, improving symptoms of rheumatoid arthritis, and overall anti-aging.
Although the popular interest in NAD+ is relatively new, the clinical experience with NAD+ treatments actually goes back several decades. Links between NAD+ levels and health were established almost a century ago. In 1937 the American chemist Conrad Elvehjem discovered that the disease pellagra is caused by a dietary deficiency of niacin (a precursor of NAD) and resulted in low NAD+ levels.
Exploring the Therapeutic Benefits of NAD+ IV Infusions
IV infusion of NAD+ is the most direct method of increasing NAD+ levels, and IV NAD+ infusions have been used since the 1950’s in the treatment of symptoms related to drug addiction and withdrawal. Dr. Paul O’Holleran of Seattle published a paper describing his experience with NAD+ IV infusions in 1961. His clinical approach was initially focused on patients suffering from alcohol withdrawal but eventually extended to many different types of drug additions. Dr. O’Hollaren’s protocol involved infusing 500-1000 mg of NAD+ daily for 4 days, then twice weekly for a month, then a maintenance dose once every two months.
In addition to IV infusions, NAD+ can be administered via subcutaneous injection and nasal spray. It is not effective given orally because NAD+ is broken down in the gastrointestinal tract rather than being absorbed. For this reason, oral precursors have been developed, including nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). These precursors reliably increase serum NAD+ levels and a number of clinical trials are currently underway that test the effect of the NAD+ precursors on a wide variety of outcomes. Despite the current popularity of NAD+, and the long clinical experience with NAD+ infusions, there is surprisingly little clinical research involving IV NAD+ published in humans. There is far more research being done on NAD+ precursors, likely because the NAD+ given via IV infusion or subcutaneous injection can be made by any pharmacy and thus there is no financial incentive to sponsor a costly research trial.
NAD+ Therapy for Cognitive Function
NAD+ depletion is associated with neurodegenerative disorders such as Alzheimer’s disease and Parkinson’s disease. There is a strong physiologic basis to suggest that reversing this depletion would improve cognitive trajectories, and indeed one of the primary areas of research for NAD+ and its precursors is in this area of neurodegenerative disorders. Studies in animal models have been promising, for example studies in rodents have demonstrated that treatment with NAD precursors improves memory and cognitive performance (e.g., through maze tests) and reduces neuroinflammation and oxidative stress. Additional encouraging findings have been reported for other types of dementia and for general age-related cognitive decline.
Thus far the human studies testing the efficacy of NAD+ and its precursors on neurodegenerative disorders have yielded equivocal results, although it is important to note that the studies have been quite short and have involved small sample sizes. Probably the most encouraging study to date was a 2023 trial from Norway that tested oral NR (1.5 g twice daily) vs. placebo for four weeks in 20 patients with Parkinson’s disease. The authors reported that clinical severity of the disease was improved significantly (as defined by MDS-UPDRS scores, a composite score used to assess severity of Parkinson’s disease) in the NR group relative to placebo, with a change in score that was felt to demonstrate clear clinical significance.
While the research experience for NAD+ and its precursors in humans remains limited, the studies that have been published consistently demonstrate its safety. This, plus the long clinical experience with NAD+ going back several decades, provides strong support for the absence of significant adverse effects. While safe, these infusions can be uncomfortable especially at higher rates of infusion. Common side effects during infusion include flushing, cramping, and chest tightness. These effects are dependent on the rate of infusion, and for this reason the infusions are given very slowly to ensure patient comfort.
Conclusion
Despite the lack of published research, the strong physiologic basis, long-standing positive clinical experience, and consistently enthusiastic patient response provide a compelling rationale for those looking for a non-conventional approach to common issues. NAD+ therapy is a promising therapy with the potential to provide general anti-aging effects as well as treat symptoms of chronic fatigue, chronic pain and inflammation, reduce addiction related cravings, improve sleep, and provide sharper mental clarity.
Looking for NAD+ IV Therapy Near Me?
Connect with Valley Healthspan for expert NAD+ IV therapy that boosts energy, enhances cognitive function, and promotes overall wellness. Our personalized treatments are designed to help you feel your best.
Call (480) 973-9042 or request a consultation online today!
References

(480) 973-9042